Home › Funds › LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE › CRL
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE position in CRL
CHARLES RIV LABS INTL INC · Health Care
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reported holding 26,634 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$7.9M, representing 2.18% of its reported portfolio and ranking #20 among its reported holdings. LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's CRL position evolved
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE first disclosed a stake in CRL in Q3 2023 at 55,334 shares (US$10.8M). The position peaked in Q1 2024 at 55,158 shares, worth US$14.9M. Across 13 filings, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 26,634 shares valued at US$7.9M — a reduction of -1,370 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2025 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 55.33K | $10.84M | New |
| Q4 2023 | 55.32K | $13.08M | Hold |
| Q1 2024 | 55.16K | $14.95M | Hold |
| Q2 2024 | 55.46K | $11.46M | Add |
| Q3 2024 | 56.53K | $11.14M | Add |
| Q4 2024 | 55.04K | $10.16M | Reduce |
| Q1 2025 | 55.99K | $8.43M | Add |
| Q2 2025 | 50.47K | $7.66M | Reduce |
| Q3 2025 | 49.91K | $7.81M | Reduce |
| Q4 2025 | 31.64K | $6.31M | Reduce |
| Q1 2026 | 28.53K | $4.92M | Reduce |
| Q2 2026 | 28.00K | $6.35M | Reduce |
| Q3 2026 | 26.63K | $7.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M sh · $320.67M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K sh · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE
FAQ
How long has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE held CRL?
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's current position in CRL?
As of Q3 2026, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE holds 26.63K shares of CRL (CHARLES RIV LABS INTL INC), valued at $7.86M, representing 2.18% of its reported portfolio and ranking #20.
Has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE been buying or selling CRL?
In the latest 13F filing (Q3 2026), LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reduced its position in CRL. The position peaked in Q1 2024 at 55.16K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.